ACOR
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
13.34M
GET INTRADAY SIGNALS
ACOR Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
38 days until earnings call
+Compare
ACOR
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
13.34M

ACOR Price Prediction, Acorda Therapeutics AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
ACOR Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Mar 27, 2023

ACOR in -7.87% downward trend, falling for three consecutive days on March 24, 2023

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ACOR declined for three days, in 341 of 371 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 09, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on ACOR as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ACOR moved below its 50-day moving average on March 09, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ACOR crossed bearishly below the 50-day moving average on March 10, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACOR entered a downward trend on February 24, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACOR advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

ACOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.143) is normal, around the industry mean (5.421). P/E Ratio (0.000) is within average values for comparable stocks, (48.137). ACOR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.988). ACOR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (0.091) is also within normal values, averaging (87.693).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ACOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Intra-Cellular Therapies (NASDAQ:ITCI), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.13B. The market cap for tickers in the group ranges from 246 to 79.44B. MKKGY holds the highest valuation in this group at 79.44B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was -10%, and the average quarterly price growth was -6%. SCYX experienced the highest price growth at 50%, while INNPF experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -67%. For the same stocks of the Industry, the average monthly volume growth was -45% and the average quarterly volume growth was -81%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 50
SMR Rating: 85
Profit Risk Rating: 93
Seasonality Score: -6 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published General Information

General Information

a maker of therapeutic products for nervous system disorders

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Blue Hill Plaza
Phone
+1 914 347-4300
Employees
122
Web
https://www.acorda.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADTH1.680.04
+2.44%
AdTheorent Holding Company
RE349.484.65
+1.35%
Everest Re Group Ltd
TCBI50.300.25
+0.50%
Texas Capital Bancshares
SNBR28.47-0.35
-1.21%
Sleep Number Corp
SISI0.60-0.02
-3.07%
Shineco

ACOR and

Correlation & Price change

A.I.dvisor tells us that ACOR and CGC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOR and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOR
1D Price
Change %
ACOR100%
+4.34%
CGC - ACOR
22%
Poorly correlated
-1.05%
CRON - ACOR
21%
Poorly correlated
+1.03%
TLRY - ACOR
21%
Poorly correlated
-0.38%
DRRX - ACOR
20%
Poorly correlated
-0.23%
ACB - ACOR
20%
Poorly correlated
+0.41%
More